Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
What will members gain?

Download Now: New Slide Deck Programme

Slide decks focusing on key results and expert analysis from FOURIER and ODYSSEY OUTCOMES – two landmark trials in PCSK9 inhibition.

Find out more »

   
Most viewed

Hot Topics

Coronary artery calcium in familial hypercholesterolaemia

 
Coronary artery calcium may have a role in stratifying short-term risk in patients with familial hypercholesterolaemia (FH, inherited high cholesterol), according to a new study. This noninvasive approach may have value in targeting treatment with a PCSK9 inhibitor to those patients at highest risk.
Read the report

VIDEO: Is coronary artery calcium a risk assessment too in FH?
Watch the video

VIDEO: Severe FH: how to define?
Watch the video

VIDEO: ESC/EAS Task Force guidance for PCSK9 inhibitors
Watch the video

From the Editors

New US Cholesterol Guidelines: The good, the bad and the ugly
 

PCSK9 Forum Editor Professor Professor Henry Ginsberg (Columbia University, New York, USA) discusses how the new guidelines might be viewed as a remake of the great spaghetti western called “The Good, the Bad, and the Ugly.”
Read the report

 
Video: AHA 2018 US Cholesterol Guidelines

Watch the video

ACC 2017